case_images: PMC2963141_01
case_images: Endometrial curetting prior to therapy, irregular cribriform glands, and mild atypia: well-differentiated endometrioid carcinoma (H&E 100x).
case_images: OGI2010-431950.001.jpg
case_images: PMC2963141_01_OGI2010-431950.001.jpg
case_images: fig1
case_images: An outpatient endometrial pipelle biopsy was performed which revealed a moderately differentiated adenocarcinoma (Figure 1) with minimal myometrial invasion (Clinical FIGO stage I).
case_images: T-shaped Femilis LNG-IUS with 28 mm long crossarm and 3 cm long and 2.4 mm wide drug delivery compartment.
case_images: OGI2010-431950.002.jpg
case_images: PMC2963141_01_OGI2010-431950.002.jpg
case_images: fig2
case_images: An LNG-IUS (Femilis, Contrel Research, Ghent, Belgium) releasing 20 mug of LNG/d was inserted (Figure 2), and advice was given to request a repeat biopsy within the next 3 to 6 months.
case_images: Sonographic view of uterus with LNG-IUS in situ. The endometrial thickness is 3.42 mm.
case_images: OGI2010-431950.003.jpg
case_images: PMC2963141_01_OGI2010-431950.003.jpg
case_images: fig3
case_images: The endometrium showed normal thickness, and there was no evidence of any endometrial abnormality or myometrial invasion (Figures 3 and 4).
case_images: 3D-sonographic view of normal uterus (transverse section) with LNG-IUS in center.
case_images: OGI2010-431950.004.jpg
case_images: PMC2963141_01_OGI2010-431950.004.jpg
case_images: fig4
case_images: The endometrium showed normal thickness, and there was no evidence of any endometrial abnormality or myometrial invasion (Figures 3 and 4).
case_images: Endometrial curetting posttherapy, small regular glands with tubal metaplasia, surrounded by decidualised stroma (H&E 100x).
case_images: OGI2010-431950.005.jpg
case_images: PMC2963141_01_OGI2010-431950.005.jpg
case_images: fig5
case_images: Histological examination of the specimen revealed a secretory endometrium without signs of hyperplasia or atypia (Figure 5).